MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities.

导出 OA

翻译打印收藏纠错

第一作者： Celia,Sequera

第一单位： Aix-Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), Turing Center for Living Systems, Parc Scientifique de Luminy, Marseille, France.

作者： Celia,Sequera ^[1] ; Margherita,Grattarola ^[1] ; Agnes,Holczbauer ^[2] ; Rosanna,Dono ^[3] ; Stefania,Pizzimenti ^[1] ; Giuseppina,Barrera ^[2] ; Kirk J,Wangensteen ^[2] ; Flavio,Maina ^[4]

作者单位： Aix-Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), Turing Center for Living Systems, Parc Scientifique de Luminy, Marseille, France. ^[1] Department of Clinical and Biological Science, University of Turin, 10125, Turin, Italy. ^[2] Division of Gastroenterology, Department of Medicine, Mayo Clinic, Rochester, NY, USA. ^[3] Division of Gastroenterology, Department of Medicine, Mayo Clinic, Rochester, NY, USA. Wangensteen.Kirk@mayo.edu. ^[4] Aix-Marseille Univ, CNRS, Developmental Biology Institute of Marseille (IBDM), Turing Center for Living Systems, Parc Scientifique de Luminy, Marseille, France. flavio.maina@univ-amu.fr. ^[5]

主题词人类(Humans);癌, 肝细胞(Carcinoma, Hepatocellular);磷脂酰肌醇蛋白聚糖类(Glypicans);肝细胞(Hepatocytes);肝肿瘤(Liver Neoplasms);原癌基因蛋白质c-myc(Proto-Oncogene Proteins c-myc)

DOI 10.1038/s41419-022-05411-6

PMID 36433941

发布时间 2023-07-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交